Histogenics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Histogenics and buy or sell other stocks, options, and ETFs commission-free!

About HSGX

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. 

CEO
Adam D. Gridley, MBA
CEOAdam D. Gridley, MBA
Employees
65
Employees65
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2000
Founded2000
Employees
65
Employees65

HSGX Key Statistics

Market cap
118.53M
Market cap118.53M
Price-Earnings ratio
-4.79
Price-Earnings ratio-4.79
Dividend yield
—
Dividend yield—
Average volume
6.60M
Average volume6.60M
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$2.11
52 Week high$2.11
52 Week low
$0.345
52 Week low$0.345
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.